FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers
are seeking to limit their reliance on Chinese contractors who
produce drugs used in clinical trials and early-stage
manufacturing, a move that is benefiting rivals in India,
according to...

Related Keywords

United States ,Shanghai ,China ,India ,London ,City Of ,United Kingdom ,Hyderabad ,Andhra Pradesh ,Chinese ,Helen Chen ,Indian Cdmos ,Rishika Sadam ,Tommy Erdei ,Michele Gershberg ,Piramal Pharma ,Peter Deyoung ,Ashish Nimgaonkar ,Ramesh Subramanian ,Maggie Fick ,Catherine Evans ,Andrew Silver ,Aragen Life Sciences ,Sai Life Sciences ,Reuters ,Piramal Pharma Solutions ,Drug Administration ,Glyscend Therapeutics ,Greater China Managing Partner ,Mordor Intelligence ,Life Sciences ,Markets ,